Literature DB >> 6317568

Stimulation of chemiluminescence and resistance against aerogenic influenza virus infection by synthetic muramyl dipeptide combined with trehalose dimycolate.

K N Masihi, W Brehmer, I Azuma, W Lange, S Müller.   

Abstract

The effect on respiratory burst of splenic cells from mice pretreated with oil-in-water emulsions of muramyl dipeptide (MDP), trehalose dimycolate (TDM), or the combination of MDP with TDM was studied by luminol-dependent chemiluminescence in response to stimulation by zymosan. Spleen cells from mice pretreated with TDM, but not those of mice treated with MDP, generated increased chemiluminescence. Spleen cells from animals pretreated with the combination of MDP and TDM exhibited markedly enhanced chemiluminescence activity. The effect of enhanced activity of preparations containing MDP combined with TDM was further examined in vivo by an aerosol infection of pretreated mice with a mouse-pathogenic influenza virus. Pretreatment with 6-O-acyl analogs and one ubiquinone derivative of MDP alone did not induce any resistance against influenza virus. Significant protection was conferred only when MDP and certain analogs were combined with TDM. The enhancement of nonspecific resistance to influenza virus infection was related to the chemical structure of the synthetic immunostimulant. A greater degree of protection was induced by the combination of TDM with the lipophilic derivatives like B 30-MDP and L-18 MDP.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6317568      PMCID: PMC263415          DOI: 10.1128/iai.43.1.233-237.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  22 in total

1.  Direct augmentation of cytolytic activity of tumor-derived macrophages and macrophage cell lines by muramyl dipeptide.

Authors:  T Taniyama; H T Holden
Journal:  Cell Immunol       Date:  1979-12       Impact factor: 4.868

2.  Plasma-dependent chemotaxis of macrophages toward BCG cell walls and the mycobacterial glycolipid P3.

Authors:  M T Kelly
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

3.  Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives.

Authors:  F Ellouz; A Adam; R Ciorbaru; E Lederer
Journal:  Biochem Biophys Res Commun       Date:  1974-08-19       Impact factor: 3.575

4.  Novel quinonyl derivatives of muramyl dipeptide possessing potent antitumor activity.

Authors:  S Kobayashi; T Fukuda; I Imada; M Fujino; I Azuma; Y Yamamura
Journal:  Chem Pharm Bull (Tokyo)       Date:  1979-12       Impact factor: 1.645

5.  Macrophage activation by mycobacterial water soluble compounds and synthetic muramyl dipeptide.

Authors:  S M Wahl; L M Wahl; J B McCarthy; L Chedid; S E Mergenhagen
Journal:  J Immunol       Date:  1979-06       Impact factor: 5.422

6.  Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs.

Authors:  L Chedid; M Parant; F Parant; P Lefrancher; J Choay; E Lederer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-05       Impact factor: 11.205

7.  Inhibition of macrophage migration by muramyl peptides.

Authors:  S Nagao; A Tanaka; Y Yamamoto; T Koga; K Onoue; T Shiba; K Kusumoto; S Kotani
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

8.  Effects of mycobacterial fractions and muramyl dipeptide on the resistance of mice to aerogenic influenza virus infection.

Authors:  K N Masihi; W Brehmer; W Lange; E Ribi
Journal:  Int J Immunopharmacol       Date:  1983

9.  Stimulation of macrophages by cord factor and by heat-killed and living BCG.

Authors:  E Yarkoni; L Wang; A Bekierkunst
Journal:  Infect Immun       Date:  1977-04       Impact factor: 3.441

10.  Increased production of superoxide anion by macrophages exposed in vitro to muramyl dipeptide or lipopolysaccharide.

Authors:  M J Pabst; R B Johnston
Journal:  J Exp Med       Date:  1980-01-01       Impact factor: 14.307

View more
  9 in total

1.  Comparison of living and nonliving vaccines for Brucella abortus in BALB/c mice.

Authors:  J A Montaraz; A J Winter
Journal:  Infect Immun       Date:  1986-08       Impact factor: 3.441

2.  Specific delayed-type hypersensitivity responses to ESAT-6 identify tuberculosis-infected cattle.

Authors:  J M Pollock; J McNair; H Bassett; J P Cassidy; E Costello; H Aggerbeck; I Rosenkrands; P Andersen
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

3.  Trehalose dimycolate from various mycobacterial species induces differing anti-infectious activities in combination with muramyl dipeptide.

Authors:  K N Masihi; W Brehmer; W Lange; H Werner; E Ribi
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

4.  Enhancement of bronchoalveolar cell recovery and stimulation of alveolar macrophage chemiluminescence and resistance to influenza virus after treatment with RU 41821 aerosol.

Authors:  A Rudent; F Michel; C Labarre; A M Quero; R Zalisz; P Smets
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

5.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Modulation of natural killer cytotoxicity by muramyl dipeptide and trehalose dimycolate incorporated in squalane droplets.

Authors:  K N Masihi; W Lange; B Rohde-Schulz
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

7.  Induction of macrophage antitumor activity by acetylated low density lipoprotein containing lipophilic muramyl tripeptide.

Authors:  J M Shaw; W S Futch; L B Schook
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins.

Authors:  P Andersen
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

9.  Muramyl peptides confer hepatoprotection against murine viral hepatitis.

Authors:  K N Masihi; H Kröger; W Lange; L Chedid
Journal:  Int J Immunopharmacol       Date:  1989
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.